FreeTender
Accepting bidsgrantSaudi Arabia

NOFO: Raising Public Awareness of Migraine in Saudi Arabia – Community Education to Support Early Recognition and Care-Seeking

Issued by Pfizer · via fundsforNGOs — grants & funding calls

Published
20 Nov 2026
Closes
23 Dec 2026
Reference
nofo-raising-public-awareness-of-migraine-in-saudi-arabia-community-education-to
Location
Saudi Arabia
Sector
Healthcare & Pharma

At a glance

Pfizer in Saudi Arabia has published a funding call in healthcare & pharma: “NOFO: Raising Public Awareness of Migraine in Saudi Arabia – Community Education to Support Early Recognition and Care-Seeking”. Submissions close on 23 December 2026, 33 days from today. Quote reference nofo-raising-public-awareness-of-migraine-in-saudi-arabia-community-education-to in any correspondence with the buyer. FreeTender has recorded 9 notices from this buyer since 2026, 4 of them currently open. There are 116 open healthcare & pharma notices in Saudi Arabia on FreeTender. Bids are submitted to the buyer through fundsforNGOs — grants & funding calls, not through FreeTender.

Key requirements

Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.

Who can apply

Eligible applicants include educational institutions, healthcare organizations, and entities focused on healthcare professional education.

Details

Pfizer’s Independent Medical Education Grant invites proposals to increase public awareness of migraine as a diagnosable, treatable neurological condition in Saudi Arabia. This initiative targets community education to promote early recognition and appropriate care-seeking behavior, particularly among women who are disproportionately affected. The deadline for submissions is 23 December 2026. This grant program aims to enhance public recognition of migraine as a serious neurological condition in Saudi Arabia. The focus is on educating the general public, patients, and caregivers about the importance of early diagnosis and the risks associated with self-medication. The initiative seeks to address the significant burden of migraine among women in the country. Pfizer offers grants of up to 150,000 SAR for projects within this initiative. The total budget available is approximately 150,000 SAR. Grants cover direct, indirect, and institutional overhead costs, with overheads capped at 28% per Pfizer policy.

Eligible applicants include:

Projects must be based in Saudi Arabia, and only organizations—not individuals—are eligible to apply.

Proposals should focus on:

Migraine is highly prevalent in Saudi Arabia, affecting 22.6% of the population, with a higher incidence among women. This grant supports projects aiming to improve migraine recognition as a treatable condition and encourages early medical intervention, thereby reducing the risks associated with self-medication. What is the funding limit per project? Each project can receive up to 150,000 SAR. Who can apply for this grant? Eligible applicants include educational institutions, healthcare organizations, and entities focused on healthcare professional education. What types of projects are supported? Projects should focus on public and patient education regarding migraine recognition and care-seeking. Is individual clinical research supported? No, this RFP does not support projects solely aimed at clinical research or data generation. What is the project duration? Projects must be completed within a 6-month period. Eligible applicants should thoroughly review the official guidelines and ensure compliance with all submission requirements. Prepare your proposal with a clear focus on the outlined objectives and submit it through the specified online portal before the deadline. For more information, visit Pfizer.

Context for bidders

We hold 9 notices from Pfizer, going back to September 2026 — 4 of them still open. There are 116 open Healthcare & Pharma tenders in Saudi Arabia. This one closes in 33 days.

Explore Saudi Arabia

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →